AIDS WEEKLY Plus - September 2004Important note: Information in this article was accurate in September 2004. The state of the art may have changed since the publication date.
Click here to return to AIDS WEEKLY PLUS main menu

DonateNow
Print this Article

HIV/AIDS Exposure: New guidelines maximize effects of occupational HIV post-exposure prophylaxis

AIDSWEEKLY Plus; Monday, September 13, 2004
Staff Medical Writers


NewsRx -- New guidelines maximize the effects of occupational HIV post-exposure prophylaxis.

"The European Commission funded a project for the standardization of the management of occupational exposures to HIV/blood-borne infections and antiretroviral post-exposure prophylaxis (PEP) in Europe. Within this project, the following recommendations and rationale were formulated by experts representative of participating countries," scientists writing in the European Journal of Epidemiology report.

"Based on assessment of the exposure, material, and source characteristics, PEP should be started as soon as possible with any triple combination of antiretrovirals approved for the treatment of HIV-infected patients; initiation is discouraged after 72 hours," wrote V. Puro and coworkers.

"Rapid HIV testing of the source could reduce inappropriate PEP. HIV testing should be performed at baseline, 4, 12, and 24 weeks," the authors said, "with additional clinical and laboratory monitoring of adverse reactions and potential toxicity at week 1 and 2.

"HIV resistance tests in the source and direct virus assays in the exposed health care worker are not recommended routinely."

Puro concluded, "These easy-to-use recommendations seek to maximize PEP effect while minimizing its toxicity and inappropriate use."

Puro and colleagues published their study in European Journal of Epidemiology (Post-exposure prophylaxis of HIV infection in healthcare workers: Recommendations for the European setting. Eur J Epidemiol. 2004;19(6):577-84.

Additional information can be obtained by contacting V. Puro, IRCCS, Ist Nazl Malattie Infett Lazzaro Spallanzoni, Via Portuense 292, I-00149 Rome, Italy.

The publisher of the European Journal of Epidemiology can be contacted at: Kluwer Academic Publ, Van Godewijckstraat 30, 3311 Gz Dordrecht, Netherlands.

The information in this article comes under the major subject areas of HIV/AIDS, Occupational Exposure, Prophylaxis, Antiretroviral Therapy and Diagnostics.

This article was prepared by AIDS Weekly editors from staff and other reports.

Reference

Puro V, Cicalini S, De Carli G, et. al., "Post-exposure prophylaxis of HIV infection in healthcare workers: recommendations for the European setting", Eur J Epidemiol. 2004;19(6):577-84.

PubMED Related articles Search

040913
AW040905


Copyright © 2004 - Charles Henderson, Publisher. All rights Reserved. Permission to reproduce granted to AEGIS by Charles W. Henderson. Authorization to reproduce for personal use granted granted by C. W. Henderson, Publisher, provided that the fee of US$4.50 per copy, per page is paid directly to the Copyright Clearance Center, 27 Congress Street, Salem, Massachusetts 01970, USA. Published by Charles Henderson, Publisher. Editorial & Publishing Office: P.O. Box 5528, Atlanta, GA 30307-0528 / Telephone: (800) 633-4931; Subscription Office: P.O. Box 830409, Birmingham, AL 35283-0409 / FAX: (205) 995-1588 http://www.newsrx.net

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright © 1980,2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.